Free Trial

Prelude Therapeutics (PRLD) Institutional Ownership

Prelude Therapeutics logo
$4.66 +0.02 (+0.43%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$4.66 0.00 (0.00%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Prelude Therapeutics (NASDAQ:PRLD)

Current
Institutional Ownership
Percentage
79.72%
Number of
Institutional Buyers
(last 12 months)
15
Total
Institutional Inflows
(last 12 months)
$3.85M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$4.23M
Get PRLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Prelude Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PRLD Institutional Buying and Selling by Quarter

Prelude Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2026 Dimensional Fund Advisors LP35,210$120K0.0%N/A0.056%
2/18/2026XTX Topco Ltd50,159$145K0.0%+222.0%0.080%
2/18/2026Sphera Funds Management LTD.122,752$356K0.1%N/A0.195%
2/18/2026Millennium Management LLC150,997$438K0.0%-86.8%0.240%
2/17/2026Price T Rowe Associates Inc. MD755,956$2.19M0.0%-13.7%1.202%
2/16/2026OMERS ADMINISTRATION Corp73,000$212K0.0%N/A0.116%
2/13/2026Marshall Wace LLP273,883$794K0.0%N/A0.436%
2/13/2026State Street Corp127,292$369K0.0%+30.4%0.202%
2/12/2026 Jane Street Group LLC111,040$322K0.0%+218.9%0.177%
2/12/2026Renaissance Technologies LLC271,300$787K0.0%-50.1%0.432%
2/10/2026Goldman Sachs Group Inc.117,477$341K0.0%+48.1%0.187%
2/9/2026Geode Capital Management LLC272,886$792K0.0%+25.4%0.434%
11/17/2025Millennium Management LLC1,147,044$1.65M0.0%+361.7%1.824%
11/14/2025Shay Capital LLC100,000$144K0.0%+33.3%0.177%
11/14/2025Bridgeway Capital Management LLC53,500$77K0.0%-39.5%0.095%
11/7/2025Vanguard Group Inc.992,854$1.43M0.0%+6.5%1.754%
8/15/2025Shay Capital LLC75,000$61K0.0%N/A0.133%
8/14/2025 Jane Street Group LLC91,753$74K0.0%N/A0.163%
8/13/2025Marshall Wace LLP41,747$34K0.0%N/A0.074%
8/12/2025XTX Topco Ltd42,573$34K0.0%+72.4%0.075%
8/8/2025Geode Capital Management LLC217,568$176K0.0%-46.3%0.385%
8/1/2025 Y Intercept Hong Kong Ltd47,788$39K0.0%N/A0.085%
5/21/2025Acadian Asset Management LLC529,327$405K0.0%+9.1%0.938%
5/16/2025AQR Capital Management LLC33,823$26K0.0%+170.7%0.078%
5/12/2025Simplex Trading LLC41,846$32K0.0%+121.2%0.096%
5/9/2025Deutsche Bank AG80,723$62K0.0%-34.8%0.185%
2/17/2025Two Sigma Investments LP231,839$296K0.0%+307.2%0.421%
2/17/2025Two Sigma Advisers LP300,000$382K0.0%+526.3%0.545%
2/17/2025Millennium Management LLC462,555$590K0.0%+188.2%0.841%
2/17/2025Jacobs Levy Equity Management Inc.666,574$850K0.0%+280.9%1.211%
2/17/2025Deutsche Bank AG123,899$159K0.0%+747.6%0.225%
2/17/2025Bridgeway Capital Management LLC111,000$142K0.0%-37.0%0.202%
2/17/2025BNP Paribas Financial Markets20,572$26K0.0%N/A0.037%
2/14/2025Boxer Capital Management LLC1,708,187$2.18M0.2%N/A3.104%
2/14/2025Northern Trust Corp83,387$106K0.0%-21.6%0.152%
2/14/2025Price T Rowe Associates Inc. MD1,029,199$1.31M0.0%-6.2%1.870%
2/13/2025Marshall Wace LLP392,155$498K0.0%+9.2%0.713%
2/13/2025Renaissance Technologies LLC634,500$809K0.0%+222.2%1.153%
2/12/2025Massachusetts Financial Services Co. MA494,497$630K0.0%-10.0%0.899%
2/12/2025JPMorgan Chase & Co.61,149$78K0.0%+925.0%0.111%
What is “gold skimming”? (Ad)

Former $900 million hedge fund manager Larry Benedict has developed a strategy he calls Gold Skimming - a way to target cash payouts from gold markets without buying a single ounce, mining stock, or ETF. With a reported 73% win rate across 19 trades and potential payouts of $2,975, $3,781, and $6,786 in a single day, Benedict has put together a free step-by-step walkthrough showing how it works whether gold climbs or pulls back.tc pixel

Watch the free walkthrough and see how Gold Skimming works today
2/6/2025Charles Schwab Investment Management Inc.117,200$149K0.0%-12.0%0.213%
1/30/2025Rhumbline Advisers166,830$213K0.0%+1,289.8%0.303%
11/19/2024Barclays PLC27,165$57K0.0%+86.0%0.049%
11/16/2024Geode Capital Management LLC391,716$811K0.0%+8.2%0.712%
11/15/2024Barclays PLC27,165$57K0.0%+86.0%0.049%
11/15/2024XTX Topco Ltd48,239$100K0.0%N/A0.088%
11/15/2024State Street Corp286,046$592K0.0%+35.1%0.520%
11/15/2024Jacobs Levy Equity Management Inc.174,979$362K0.0%+885.2%0.318%
11/14/2024Walleye Capital LLC83,175$172K0.0%+446.2%0.151%
11/12/2024Massachusetts Financial Services Co. MA549,530$1.14M0.0%+5.2%0.999%
10/10/2024Exchange Traded Concepts LLC64,409$133K0.0%+32.2%0.153%
8/15/2024The Manufacturers Life Insurance Company70,045$267K0.0%-3.1%0.166%
8/9/2024Renaissance Technologies LLC206,600$787K0.0%-15.6%0.491%
8/9/2024Dimensional Fund Advisors LP29,074$111K0.0%+103.2%0.069%
8/9/2024Massachusetts Financial Services Co. MA522,375$1.99M0.0%+2.8%1.241%
7/26/2024Bank of New York Mellon Corp36,276$138K0.0%-9.5%0.086%
5/16/2024Kennedy Capital Management LLC25,035$119K0.0%N/A0.059%
5/15/2024Price T Rowe Associates Inc. MD941,971$4.47M0.0%-9.7%2.239%
5/10/2024Acadian Asset Management LLC22,110$104K0.0%+42.7%0.053%
5/10/2024Vanguard Group Inc.1,016,999$4.82M0.0%+1.0%2.417%
2/15/2024Boxer Capital LLC2,568,287$10.97M0.5%+2.9%4.684%
2/14/2024Pale Fire Capital SE63,581$271K0.0%+106.6%0.116%
1/12/2024SG Americas Securities LLC13,100$56K0.0%N/A0.024%
1/5/2024Exchange Traded Concepts LLC44,087$188K0.0%+34.0%0.080%
11/14/2023Pale Fire Capital SE30,781$95K0.0%N/A0.056%
11/13/2023FMR LLC5,131,433$15.86M0.0%-13.6%9.359%
11/7/2023Barclays PLC13,316$42K0.0%+120.0%0.024%
10/27/2023TD Asset Management Inc160,652$496K0.0%+100.0%0.293%
10/18/2023Exchange Traded Concepts LLC32,907$102K0.0%+29.4%0.060%
9/21/2023Barclays PLC6,052$27K0.0%-41.4%0.011%
8/15/2023Boxer Capital LLC2,495,018$11.23M0.5%+256.9%4.552%
8/9/2023TD Asset Management Inc80,326$361K0.0%+182.4%0.147%
7/20/2023Exchange Traded Concepts LLC25,428$114K0.0%N/A0.053%
5/16/2023Boxer Capital LLC699,047$3.99M0.2%N/A1.458%
5/1/2023Virtu Financial LLC11,201$64K0.0%N/A0.023%
2/14/2023683 Capital Management LLC28,631$173K0.0%N/A0.060%
2/13/2023GSA Capital Partners LLP47,801$289K0.0%-11.8%0.100%
2/10/2023New York Life Investment Management LLC82,000$495K0.0%+11.7%0.171%
2/9/2023Citigroup Inc.60,072$363K0.0%+604.1%0.126%
2/7/2023Bleakley Financial Group LLC22,325$135K0.0%N/A0.047%
11/15/2022Caxton Associates LP85,992$568K0.1%+2.5%0.180%
11/14/2022PDT Partners LLC12,641$84K0.0%-71.1%0.026%
11/9/2022Massachusetts Financial Services Co. MA513,293$3.39M0.0%+7.3%1.073%
10/25/2022Denali Advisors LLC8,200$54K0.0%N/A0.017%
8/16/2022Corton Capital Inc.15,586$81K0.1%+42.8%0.033%
8/16/2022Delphia USA Inc.16,940$88K0.1%N/A0.035%
8/13/2022Massachusetts Financial Services Co. MA478,525$2.50M0.0%-0.7%1.000%
8/12/2022Virtus ETF Advisers LLC24,005$125K0.0%+84.0%0.050%
7/19/2022Commonwealth Equity Services LLC16,617$86K0.0%-18.8%0.035%
5/11/2022Massachusetts Financial Services Co. MA482,119$3.33M0.0%+2.8%1.012%
What is “gold skimming”? (Ad)

Former $900 million hedge fund manager Larry Benedict has developed a strategy he calls Gold Skimming - a way to target cash payouts from gold markets without buying a single ounce, mining stock, or ETF. With a reported 73% win rate across 19 trades and potential payouts of $2,975, $3,781, and $6,786 in a single day, Benedict has put together a free step-by-step walkthrough showing how it works whether gold climbs or pulls back.tc pixel

Watch the free walkthrough and see how Gold Skimming works today
5/11/2022GSA Capital Partners LLP23,201$160K0.0%N/A0.049%
5/6/2022IndexIQ Advisors LLC56,750$392K0.0%N/A0.119%
5/5/2022New York State Common Retirement Fund4,992$34K0.0%-45.1%0.010%
5/4/2022Commonwealth Equity Services LLC20,467$141K0.0%-10.4%0.043%
3/3/2022Walleye Capital LLC41,954$522K0.0%N/A0.089%
2/14/2022PDT Partners LLC35,907$447K0.0%N/A0.076%
2/14/2022Virtus ETF Advisers LLC13,815$172K0.1%+119.6%0.029%
2/14/2022Point72 Hong Kong Ltd3,872$48K0.0%+141.7%0.008%
2/11/2022Ensign Peak Advisors Inc8,080$101K0.0%N/A0.017%
2/11/2022Parkwood LLC12,667$158K0.0%N/A0.027%


PRLD Institutional Ownership - Frequently Asked Questions

During the previous two years, 36 institutional investors and hedge funds held shares of Prelude Therapeutics. The most heavily invested institutionals were Price T Rowe Associates Inc. MD ($2.19M), Boxer Capital Management LLC ($2.18M), Vanguard Group Inc. ($1.43M), Jacobs Levy Equity Management Inc. ($850K), Marshall Wace LLP ($794K), Geode Capital Management LLC ($792K), and Renaissance Technologies LLC ($787K).Learn more on Prelude Therapeutics' institutional investors.

79.72% of Prelude Therapeutics' stock is owned by institutional investors. Learn more on PRLD's institutional investor holdings.

Of the 30 institutional investors that purchased Prelude Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Boxer Capital Management LLC ($1.71M), Millennium Management LLC ($1.20M), Jacobs Levy Equity Management Inc. ($648.81K), Renaissance Technologies LLC ($437.60K), Marshall Wace LLP ($348.65K), Two Sigma Advisers LP ($252.10K), and Two Sigma Investments LP ($174.91K).

Institutional investors have bought a total of 2,062,154 shares in the last 24 months. This purchase volume represents approximately $3.85M in transactions.

The following institutional investors have sold Prelude Therapeutics stock in the last 24 months: Millennium Management LLC ($996.05K), Renaissance Technologies LLC ($272.70K), Geode Capital Management LLC ($187.39K), Price T Rowe Associates Inc. MD ($120.38K), and Bridgeway Capital Management LLC ($35K).

Institutional investors have sold a total of 1,611,516 shares in the last 24 months. This volume of shares sold represents approximately $4.23M in transactions.



This page (NASDAQ:PRLD) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners